153 related articles for article (PubMed ID: 16019449)
21. Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide.
Braslis KG; Davi RC; Nelson E; Civantos F; Soloway MS
Urology; 1995 Feb; 45(2):329-31. PubMed ID: 7855985
[TBL] [Abstract][Full Text] [Related]
22. [Disseminated intravascular coagulation during cancer of the prostate with diffuse hematogenic dissemination].
Conard J; James JM; Dautzenberg B; Berault-Audoin J; Samama M; Diebold J; Bilski-Pasquier G; Bousser J
Nouv Presse Med; 1976 Dec; 5(42):2867-8. PubMed ID: 995623
[No Abstract] [Full Text] [Related]
23. Disseminated intravascular coagulation in carcinoma of prostate: role of estrogen therapy.
Goldenberg SL; Fenster HN; Perler Z; McLoughlin MG
Urology; 1983 Aug; 22(2):130-2. PubMed ID: 6879882
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer: beware of disseminated intravascular coagulation.
Desai M; John B; Evans G; Eddy B
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25819815
[TBL] [Abstract][Full Text] [Related]
25. Disseminated intravascular coagulopathy in a patient undergoing total hip arthroplasty for carcinoma. A case report.
Unger AS; Booth RE
Clin Orthop Relat Res; 1984 Mar; (183):76-8. PubMed ID: 6697605
[TBL] [Abstract][Full Text] [Related]
26. Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.
Mottet N; Peneau M; Mazeron JJ; Molinie V; Richaud P
Eur Urol; 2012 Aug; 62(2):213-9. PubMed ID: 22502942
[TBL] [Abstract][Full Text] [Related]
27. Recurrent epistaxis as a presenting sign of androgen-sensitive metastatic prostate cancer.
Lim HY; Agarwal AM; Agarwal N; Ward JH
Singapore Med J; 2009 May; 50(5):e178-80. PubMed ID: 19495504
[TBL] [Abstract][Full Text] [Related]
28. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
29. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
30. Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer.
Duran I; Tannock IF
J Gen Intern Med; 2006 Nov; 21(11):C6-8. PubMed ID: 17026724
[TBL] [Abstract][Full Text] [Related]
31. Disseminated intravascular coagulation complicating Ender's nailing of a pathologic fracture in prostatic carcinoma. A case report.
Olson SA; Humphreys WG; Allen WC
Clin Orthop Relat Res; 1990 Sep; (258):242-4. PubMed ID: 2394052
[TBL] [Abstract][Full Text] [Related]
32. Aortic aneurysm-induced disseminated intravascular coagulation.
Aboulafia DM; Aboulafia ED
Ann Vasc Surg; 1996 Jul; 10(4):396-405. PubMed ID: 8879398
[TBL] [Abstract][Full Text] [Related]
33. Increased warfarin sensitivity as an early manifestation of occult prostate cancer with chronic disseminated intravascular coagulation.
Munter G; Hershko C
Acta Haematol; 2001; 105(2):97-9. PubMed ID: 11408712
[TBL] [Abstract][Full Text] [Related]
34. Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localized prostate cancer (T1-2): a retrospective study.
Raina R; Pahalajani G; Agarwal A; Zippe C
Asian J Androl; 2007 Mar; 9(2):253-8. PubMed ID: 17334592
[TBL] [Abstract][Full Text] [Related]
35. [Prostate cancer with disseminated carcinomatosis of bone marrow initially presenting with disseminated intravascular coagulation syndrome: a case report].
Minato N; Takada T; Koga M; Sugao H
Hinyokika Kiyo; 2012 May; 58(5):249-53. PubMed ID: 22767279
[TBL] [Abstract][Full Text] [Related]
36. [Clinical study on prostate cancer initially presenting with disseminated intravascular coagulation syndrome].
Ohtake N; Kurita S; Fukabori Y; Imai K; Yamanaka H; Nakata S; Sato J; Kurihara J; Mashimo M; Sekihara T; Saruki K; Kawashima K; Takahashi H; Tsuchiya K; Okabe K; Jimbo S; Kurita M
Hinyokika Kiyo; 1998 Jun; 44(6):387-90. PubMed ID: 9719936
[TBL] [Abstract][Full Text] [Related]
37. Resolution of thrombocytopenia secondary to disseminated intravascular coagulation with docetaxel chemotherapy in prostate cancer.
Talebi TN; Manoharan M; Singal R
Am J Ther; 2012 Jan; 19(1):e59-61. PubMed ID: 20535002
[TBL] [Abstract][Full Text] [Related]
38. Leuprolide plus flutamide: combined androgen blockade in the treatment of advanced prostate cancer.
Chodoff L
Mt Sinai J Med; 1990 May; 57(3):171-3. PubMed ID: 2115128
[No Abstract] [Full Text] [Related]
39. Localized amyloidosis of the seminal vesicle. Possible association with hormonally treated prostatic adenocarcinoma.
Unger PD; Wang Q; Gordon RE; Stock R; Stone N
Arch Pathol Lab Med; 1997 Dec; 121(12):1265-8. PubMed ID: 9431316
[TBL] [Abstract][Full Text] [Related]
40. [-Coagulopathy suggestive of a primary fibrinolysis after head injuries with brain death-].
Bonnemaison J; Thicoïpé M; Dixmérias F; Guérin V
Ann Fr Anesth Reanim; 1998; 17(3):275-7. PubMed ID: 9750742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
